111, Inc. Sponsored ADR (NASDAQ:YI – Get Free Report) saw a significant drop in short interest in the month of April. As of April 30th, there was short interest totaling 13,805 shares, a drop of 45.1% from the April 15th total of 25,129 shares. Currently, 0.3% of the shares of the stock are sold short. Based on an average trading volume of 11,742 shares, the days-to-cover ratio is currently 1.2 days.
111 Stock Performance
Shares of NASDAQ:YI opened at $5.79 on Friday. 111 has a twelve month low of $2.48 and a twelve month high of $11.17. The firm has a market cap of $50.89 million, a PE ratio of -5.79 and a beta of 0.66. The business has a fifty day moving average of $6.50 and a 200-day moving average of $5.49.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings cut 111 from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, May 7th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, 111 has a consensus rating of “Sell”.
111 Company Profile
111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.
111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.
Featured Articles
- Five stocks we like better than 111
- MarketBeat Week in Review – 05/11 – 05/15
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.
